GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (OTCPK:CMPUY) » Definitions » 5-Year Yield-on-Cost %

CMPUY (CompuGroup Medical SE KgaA) 5-Year Yield-on-Cost % : 7.46 (As of Apr. 10, 2025)


View and export this data going back to 2012. Start your Free Trial

What is CompuGroup Medical SE KgaA 5-Year Yield-on-Cost %?

CompuGroup Medical SE KgaA's yield on cost for the quarter that ended in Dec. 2024 was 7.46.


The historical rank and industry rank for CompuGroup Medical SE KgaA's 5-Year Yield-on-Cost % or its related term are showing as below:

CMPUY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.82   Med: 1.49   Max: 12.61
Current: 7.46


During the past 13 years, CompuGroup Medical SE KgaA's highest Yield on Cost was 12.61. The lowest was 0.82. And the median was 1.49.


CMPUY's 5-Year Yield-on-Cost % is ranked better than
85.82% of 275 companies
in the Healthcare Providers & Services industry
Industry Median: 2.78 vs CMPUY: 7.46

Competitive Comparison of CompuGroup Medical SE KgaA's 5-Year Yield-on-Cost %

For the Health Information Services subindustry, CompuGroup Medical SE KgaA's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CompuGroup Medical SE KgaA's 5-Year Yield-on-Cost % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where CompuGroup Medical SE KgaA's 5-Year Yield-on-Cost % falls into.


;
;

CompuGroup Medical SE KgaA 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of CompuGroup Medical SE KgaA is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

CompuGroup Medical SE KgaA  (OTCPK:CMPUY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


CompuGroup Medical SE KgaA 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.